Tibet Rhodiola Pharmaceutical Holding Co (600211) — Cash Flow Reinvestment Rate
Tibet Rhodiola Pharmaceutical Holding Co (600211) has a Cash Flow Reinvestment Rate of 0.07x as of December 2025, reinvesting CN¥20.26 Million (capex CN¥4.98 Million plus investments CN¥15.27 Million) from operating cash flow of CN¥297.86 Million. Explore how much does Tibet Rhodiola Pharmaceutical Holding Co reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tibet Rhodiola Pharmaceutical Holding Co Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Tibet Rhodiola Pharmaceutical Holding Co across 25 annual periods. Also explore Tibet Rhodiola Pharmaceutical Holding Co (600211) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Tibet Rhodiola Pharmaceutical Holding Co (1999–2025)
Year-by-year capital reinvestment analysis for Tibet Rhodiola Pharmaceutical Holding Co. For live market cap and broader valuation context, see Tibet Rhodiola Pharmaceutical Holding Co market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.73x | CN¥751.90 Million | CN¥1.03 Billion | CN¥15.96 Million | ▲ +70.7% |
| 2024 | 0.43x | CN¥426.90 Million | CN¥994.79 Million | CN¥37.60 Million | ▼ -45.6% |
| 2023 | 0.79x | CN¥853.57 Million | CN¥1.08 Billion | CN¥21.69 Million | ▲ +15.1% |
| 2022 | 0.69x | CN¥573.65 Million | CN¥837.38 Million | CN¥101.96 Million | ▼ -67.0% |
| 2021 | 2.08x | CN¥760.55 Million | CN¥366.53 Million | CN¥425.58 Million | ▲ +77.2% |
| 2020 | 1.17x | CN¥501.29 Million | CN¥428.17 Million | CN¥221.29 Million | ▲ +150.3% |
| 2019 | 0.47x | CN¥229.00 Million | CN¥489.59 Million | CN¥49.00 Million | ▼ -33.5% |
| 2018 | 0.70x | CN¥203.37 Million | CN¥289.22 Million | CN¥23.37 Million | ▼ -90.5% |
| 2017 | 7.41x | CN¥677.98 Million | CN¥91.46 Million | CN¥607.98 Million | ▲ +446.0% |
| 2016 | 1.36x | CN¥339.72 Million | CN¥250.21 Million | CN¥9.64 Million | ▼ -41.8% |
| 2015 | 2.33x | CN¥312.46 Million | CN¥133.93 Million | CN¥10.66 Million | ▲ +1809.4% |
| 2013 | 0.12x | CN¥34.12 Million | CN¥279.22 Million | CN¥34.12 Million | ▲ +55.4% |
| 2012 | 0.08x | CN¥4.42 Million | CN¥56.20 Million | CN¥4.42 Million | ▼ -58.9% |
| 2011 | 0.19x | CN¥2.31 Million | CN¥12.09 Million | CN¥2.31 Million | ▼ -85.9% |
| 2010 | 1.36x | CN¥2.58 Million | CN¥1.90 Million | CN¥2.58 Million | ▲ +555.4% |
| 2009 | 0.21x | CN¥3.70 Million | CN¥17.88 Million | CN¥3.70 Million | ▼ -7.5% |
| 2008 | 0.22x | CN¥4.80 Million | CN¥21.46 Million | CN¥4.80 Million | ▼ -52.7% |
| 2006 | 0.47x | CN¥15.90 Million | CN¥33.63 Million | CN¥15.90 Million | ▲ +26.5% |
| 2005 | 0.37x | CN¥7.07 Million | CN¥18.92 Million | CN¥7.07 Million | ▼ -42.4% |
| 2004 | 0.65x | CN¥17.45 Million | CN¥26.90 Million | CN¥17.45 Million | ▲ +33.8% |
| 2003 | 0.48x | CN¥22.88 Million | CN¥47.20 Million | CN¥22.88 Million | ▼ -84.4% |
| 2002 | 3.11x | CN¥102.14 Million | CN¥32.85 Million | CN¥102.14 Million | ▼ -39.7% |
| 2001 | 5.15x | CN¥79.72 Million | CN¥15.47 Million | CN¥79.72 Million | ▼ -10.6% |
| 2000 | 5.76x | CN¥118.45 Million | CN¥20.55 Million | CN¥118.45 Million | ▼ -79.5% |
| 1999 | 28.15x | CN¥63.25 Million | CN¥2.25 Million | CN¥63.25 Million | — |